Related Experiment Video

Updated: Feb 19, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.0K

HbA1C - overall glycemia marker and hemolytic anemia indicator

Marica Jandrić Balen1, Vesna Lukenda, Ivan Jandrić

  • 1Department of Internal Medicine, General Hospital Dr. Josip Benčević, Slavonski Brod, Croatia. marica@jandric.com

Medicinski Glasnik : Official Publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina
|August 29, 2012
PubMed

Insights

Glycated hemoglobin A1C (HbA1C) can be falsely low in patients with shortened erythrocyte lifespan, like those with hemolytic anemia. This makes HbA1C an unreliable measure of blood sugar control in diabetic patients with hemolysis.

Area of Science:

  • Endocrinology
  • Hematology

Background:

  • Glycated hemoglobin A1C (HbA1C) is a key marker for assessing long-term glycemic control in diabetes management, with targets typically below 6.5% to mitigate chronic complication risks.
  • Erythrocyte lifespan significantly influences HbA1C levels, as it reflects average blood glucose over approximately 3 months.
  • Conditions causing shortened erythrocyte lifespan can lead to falsely decreased HbA1C values, complicating accurate glycemic assessment.

Observation:

  • A case study involving a 72-year-old diabetic patient with suspected iatrogenic autoimmune hemolytic anemia highlighted discrepancies in HbA1C readings.
  • The patient's condition, characterized by a shortened erythrocyte lifespan due to hemolytic anemia, resulted in an inaccurately low HbA1C value.
  • This observation underscores the potential for hemolysis to mask true glycemic levels.

Findings:

  • HbA1C may serve as a preliminary screening tool for hemolysis in non-diabetic individuals.
  • However, in diabetic patients concurrently experiencing hemolytic disease, HbA1C is a poor indicator of both overall glycemia and the severity of hemolysis.
  • The interplay between diabetes and hemolytic anemia significantly compromises the reliability of HbA1C as a diagnostic marker.

Implications:

  • Clinicians should consider erythrocyte lifespan and potential hemolysis when interpreting HbA1C values, especially in diabetic patients.
  • Alternative or supplementary methods for assessing glycemic control may be necessary in diabetic patients with hemolytic conditions.
  • Further research is warranted to establish reliable markers for glycemic control in complex cases involving concurrent diabetes and hemolytic anemia.

More Related Videos

A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering05:18

A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering

Published on: December 7, 2016

10.2K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
625
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K